Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Melanoma 1Lymphatic Metastasis 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms, Male 1Anus Neoplasms 1

Interventions

Radiosurgery 2encorafenib 1binimetinib 1alovudine 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Metastasectomy 1Leuprolide 1Goserelin 1Docetaxel 1DEAE-Dextran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphatic Metastasis × alovudine × Clear all
NCT04221438 2026-05-29

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡